155 related articles for article (PubMed ID: 18602014)
1. Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist.
Li X; Liu KL; Zheng JQ; Chi MG; Dong JJ; Dong SJ; Gong ZH
Pulm Pharmacol Ther; 2008 Oct; 21(5):780-7. PubMed ID: 18602014
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL
J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217
[TBL] [Abstract][Full Text] [Related]
3. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung.
Janosi T; Peták F; Fontao F; Morel DR; Beghetti M; Habre W
Exp Physiol; 2008 Nov; 93(11):1210-9. PubMed ID: 18567602
[TBL] [Abstract][Full Text] [Related]
5. Aortic vasoconstriction related to smooth muscle cells ET-A and ET-B receptors is not involved in hypoxia-induced sustained systemic arterial hypertension in rats.
Barbier J; Reboul C; Goret L; Saïag B; Catheline M; Gibault A; Dauzat M; Obert P; Tanguy S
Vascul Pharmacol; 2007 Oct; 47(4):209-14. PubMed ID: 17669692
[TBL] [Abstract][Full Text] [Related]
6. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
7. Novel dual endothelin receptor antagonist macitentan reverses severe pulmonary arterial hypertension in rats.
Kunita-Takanezawa M; Abe K; Hirooka Y; Kuwabara Y; Hirano K; Oka M; Sunagawa K
J Cardiovasc Pharmacol; 2014 Nov; 64(5):473-80. PubMed ID: 25084082
[TBL] [Abstract][Full Text] [Related]
8. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia.
Allahdadi KJ; Cherng TW; Pai H; Silva AQ; Walker BR; Nelin LD; Kanagy NL
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H434-40. PubMed ID: 18515645
[TBL] [Abstract][Full Text] [Related]
9. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Frasch HF; Marshall C; Marshall BE
Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
[TBL] [Abstract][Full Text] [Related]
12. Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats.
Itoh H; Yokochi A; Yamauchi-Kohno R; Maruyama K
Eur J Pharmacol; 1999 Jul; 376(3):233-8. PubMed ID: 10448881
[TBL] [Abstract][Full Text] [Related]
13. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
[TBL] [Abstract][Full Text] [Related]
14. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
Oparil S; Chen SJ; Meng QC; Elton TS; Yano M; Chen YF
Am J Physiol; 1995 Jan; 268(1 Pt 1):L95-100. PubMed ID: 7840234
[TBL] [Abstract][Full Text] [Related]
16. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs.
Muramatsu M; Rodman DM; Oka M; McMurtry IF
Am J Physiol; 1997 May; 272(5 Pt 1):L807-12. PubMed ID: 9176242
[TBL] [Abstract][Full Text] [Related]
18. The chemical syntheses and bioactivities of novel peptide-based endothelin antagonists.
Yu W; Liang Y; Liu K; Zhao Y; Fei G; Wang H
J Pept Res; 2002 Mar; 59(3):134-8. PubMed ID: 11985707
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study.
Tjen-A-Looi S; Ekman R; Osborn J; Keith I
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2246-53. PubMed ID: 8997280
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1130-7. PubMed ID: 9399985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]